Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on developing novel treatments for cancer and its life-threatening complications. Cantex’s pipeline consists of three product candidates – Azeliragon, Dicopp® and DSTAT. These drugs are in clinical development for cancers for which innovative and more effective treatments are greatly needed. Cantex is planning clinical trials of azeliragon as...
Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on developing novel treatments for cancer and its life-threatening complications. Cantex’s pipeline consists of three product candidates – Azeliragon, Dicopp® and DSTAT. These drugs are in clinical development for cancers for which innovative and more effective treatments are greatly needed. Cantex is planning clinical trials of azeliragon as a potential treatment of life-threatening complications of cancer.

List your booth number for exhibitions, ask us